A small skin wound often heals so completely that within a few weeks, people can no longer even notice its trace. Repairing damaged tissue in the brain is a far more complex task. A stroke or trauma can impair a person’s ability to move, speak, or remember. Restoring lost function sometimes requires lengthy rehabilitation and is not always fully achieved.
The reason lies in the brain’s unique structure: the mere presence of a nerve cell is not enough. It must establish appropriate connections with other cells and participate in the overall network’s functioning. Therefore, repairing the brain is a far more difficult task than simply filling the damaged area with new cells.
Regenerative medicine aims to solve precisely this problem. Scientists are investigating whether lost neural tissue can be replaced with the help of stem cells and brain organoids. Some approaches are already being tested in humans, while others are still being evaluated in animal models.
To What Extent Can the Brain Repair Itself?
The brain does not remain completely inactive after an injury. It can alter existing neural connections and reorganize its functioning to some extent. This ability is called neuroplasticity, and a significant part of rehabilitation relies exactly on it.
For example, repetitive exercises after a stroke help individuals relearn movement. The surviving neural network modifies itself based on experience, facilitating the restoration of lost function. The outcome depends on the location and extent of the damage, the individual’s condition, and the rehabilitation process.
Functional improvement does not automatically mean that new neural tissue has formed in place of the dead cells. Neuroplasticity and tissue regeneration are distinct processes. The brain can make better use of remaining resources, but completely repairing a broadly damaged area often exceeds its natural capabilities.
This is somewhat akin to a road closure in a city: to reach a destination, traffic is redirected to other streets. The closed road is not repaired by this, yet movement remains possible. Similarly, in the brain, the reorganization of the surviving neural network helps bring back some lost abilities, even though the damaged tissue has not grown anew.
Where Can We Source New Nerve Cells?
Stem cells can self-renew and, depending on their type, differentiate into various specialized cells. Pluripotent stem cells hold particular significance in research, as they can yield almost any cell type in the body.
One way to obtain such cells is by reprogramming an already mature cell. For instance, a skin cell can be reverted to a state from which various cell types will develop. The resulting cell is called an induced pluripotent stem cell.
Following this, scientists guide its development using appropriate conditions and molecular signals. This method allows for the generation of nerve cells as well. Consequently, the idea of creating the exact cells a patient’s brain needs from their own skin cells is no longer merely science fiction.
The primary challenge lies in developing safe and effective treatments. The brain contains many different neurons, and one cell type cannot simply replace the function of another. Transplant material must be meticulously selected and tested: what cells it contains, how mature they are, and how they behave post-transplantation.
What is a Brain Organoid?
In addition to obtaining individual nerve cells, scientists can also grow three-dimensional tissue structures. A brain organoid is a model generated from stem cells that replicates certain processes of brain development and specific tissue characteristics.
Organoids are sometimes referred to as “mini-brains,” though this term is misleading. They do not possess the complete architecture and capabilities of a human brain. They are simplified models used to study the development, interaction, and diseases of neural cells.
From a transplantation perspective, the potential advantage of an organoid lies in its organization: it can contain various cell types and pre-established connections between them. Scientists are testing how well such a structure can integrate into a damaged area and connect with the existing neural network.
This advantage comes with its own complications. The composition and maturity level of organoids are not always uniform. However, for therapeutic use, it is essential that the properties of the generated tissue are highly controllable and reproducible.
Can New Tissue Integrate into the Brain’s Functioning?
The survival of the transplanted cell is only the first step. Next, it must mature, connect with the appropriate cells, and engage in receiving and transmitting information. This exact process is what is meant by functional integration.
Transplanting a new neuron can be compared to adding a new musician to an orchestra. Simply playing the instrument is not enough; the musician must play at the right time and keep in sync with the rest. A neuron must also receive signals from the right cells and transmit them to the appropriate targets. The mere fact that a cell is alive and electrically active does not yet mean it is aiding brain function.
In a study published in 2023, human brain organoids were transplanted into the damaged visual cortex of adult rats. Researchers documented signs of structural and functional connectivity with the host’s neural network. A subset of neurons within the transplanted tissue even responded to visual stimuli.
This is a significant finding: the organoid did not remain an isolated group of cells acting independently. It received information from the host’s visual system. However, such a reaction does not yet mean that the animal’s normal vision was fully restored, much less guarantee the same outcome in humans.
Twenty-four studies in this direction were summarized by neuroscientists Zaal Kokaia and Yu-Ping Shen in a systematic review published in 2025. The experiments they analyzed demonstrate that organoids transplanted into an animal brain can survive, mature, and connect with the host’s neural network. The next challenge is to determine how reliably this connection translates into the improvement of lost function and how safe the approach will be for humans.
What is Already Being Tested in Humans?
One of the most advanced areas for neural cell replacement is Parkinson’s disease. Its motor symptoms are closely linked to the loss of dopamine-producing neurons. Therefore, researchers have a relatively clear target: replenishing the loss of a specific type of cell.
In a Japanese study published in Nature in 2025, seven patients received transplants of dopaminergic progenitor cells derived from induced pluripotent stem cells. The results indicated the survival of the transplanted cells and the production of dopamine. During the observation period, no tumor formations were detected, and signs of potential clinical benefit were also noted.
Another early-stage study published the same year tested embryonic stem cell-derived dopaminergic progenitors in twelve patients. Here, too, the main goal was to assess safety and tolerability.
These are small, open-label trials; thus, larger, properly controlled studies are needed to definitively confirm efficacy. It should also be considered that replacing dopamine-producing cells does not automatically mean eradicating all manifestations of Parkinson’s disease or halting its progression.
These examples involve the transplantation of specific cell types. Repairing a damaged brain with organoids is a different approach and is currently at an earlier experimental stage.
What is the Main Obstacle?
The primary task is safety. The transplant material must not contain any cells that could multiply uncontrollably or form undesirable tissue. Consequently, strict control over cell development and long-term post-transplantation monitoring are essential.
The immune response is also critical: the body may reject foreign tissue. Using a patient’s own cells creates an opportunity to mitigate this problem, although it does not eliminate other risks or the need for rigorous quality control.
An additional complication for organoids is blood supply. Tissue requires oxygen and nutrients; its growth is limited without adequate vascularization. It also remains to be determined which timing, location, and developmental stage of the tissue yield the best transplantation results.
Ultimately, success must manifest in the patient’s daily life: whether they can move better, speak, or perform everyday tasks independently. The mere presence and electrical activity of new tissue are insufficient metrics for this.
Science has already taken significant steps toward repairing the damaged brain. The main task now is ensuring that nerve cells grown in the laboratory become a safely functioning part of the brain and facilitate the return of lost abilities for people.
